SCHEMBL6833154

SCHEMBL6833154

N#Cc1ccc(NC(=O)c2cncc(-c3cccc(C(F)(F)F)c3)c2)c(C(=O)O)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.54
MAPT P10636 1/20 0.54
SAE1 Q9UBE0 1/20 0.54
UBA2 Q9UBT2 1/20 0.54
RXFP1 Q9HBX9 5/20 0.50
ABL1 P00519 1/20 0.47
KCNH2 Q12809 1/20 0.45
SCN10A Q9Y5Y9 1/20 0.45
CCNC P24863 1/20 0.45
CDK8 P49336 1/20 0.45
CSF1R P07333 2/20 0.44
KIT P10721 2/20 0.44
DHODH Q02127 1/20 0.44
ALDH1A1 P00352 1/20 0.43
SERPINE1 P05121 1/20 0.43
XDH P47989 1/20 0.42
PIK3CA P42336 1/20 0.42
ADCY1 Q08828 1/20 0.42
TRPM2 O94759 1/20 0.41
NTRK1 P04629 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6833875 0.89 KDM4E (0.52) KDM4EMAPTSAE1UBA2RXFP1
SCHEMBL6833755 0.87 KCNH2 (0.55) KDM4EMAPTSAE1UBA2KCNH2
SCHEMBL6834009 0.83 CTSA (0.47) KDM4EMAPTSAE1UBA2RXFP1
SCHEMBL6830649 0.82 KCNH2 (0.54) KDM4EMAPTSAE1UBA2KCNH2
SCHEMBL1316878 0.81 ACLY (0.60) KDM4EMAPTSAE1UBA2RXFP1
SCHEMBL6834140 0.80 SCN10A (0.54) KCNH2SCN10ACCNCCDK8SERPINE1
SCHEMBL6830011 0.78 SERPINE1 (0.49) MAPTKCNH2SCN10AALDH1A1SERPINE1
SCHEMBL6833241 0.78 MAPK14 (0.47) KDM4EMAPTKCNH2SCN10AALDH1A1
SCHEMBL6835793 0.78 KCNH2 (0.49) KCNH2SCN10ACCNCCDK8ALDH1A1
SCHEMBL6834158 0.78 XDH (0.54) KDM4EMAPTSAE1UBA2KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed
WO-2004018428-A1 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110802-A1 Antibacterial benzoic acid derivatives GABRD, GABBR1, GABRA1 KDM4E 1240/4885MAPT 4759/4885SAE1 1185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.